|
US4179497A
(en)
*
|
1973-12-17 |
1979-12-18 |
Merck & Co., Inc. |
Solid state ophthalmic medication
|
|
US4003991A
(en)
*
|
1974-08-27 |
1977-01-18 |
National Patent Development Corporation |
Ophthalmic formulation
|
|
US4183356A
(en)
*
|
1975-06-05 |
1980-01-15 |
Merck & Co., Inc. |
Ophthalmic applicator device
|
|
NL188266C
(nl)
*
|
1975-07-29 |
1992-05-18 |
Merck & Co Inc |
Werkwijze ter bereiding van een oogheelkundig inplantaat.
|
|
US4077407A
(en)
*
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
JPS54145207A
(en)
*
|
1978-04-30 |
1979-11-13 |
Agency Of Ind Science & Technol |
High viscosity eye lotion
|
|
US4287175A
(en)
*
|
1978-06-22 |
1981-09-01 |
Merck & Co., Inc. |
Contact lens wetting agents
|
|
US4281654A
(en)
*
|
1980-04-07 |
1981-08-04 |
Alza Corporation |
Drug delivery system for controlled ocular therapy
|
|
US4432964A
(en)
*
|
1981-08-24 |
1984-02-21 |
Alza Corporation |
Topical composition containing steroid in two forms released independently from polymeric carrier
|
|
US4730013A
(en)
*
|
1981-10-08 |
1988-03-08 |
Merck & Co., Inc. |
Biosoluble ocular insert
|
|
PT75625B
(en)
*
|
1981-10-08 |
1985-12-09 |
Merck & Co Inc |
Process for preparing biosoluble ocular insert
|
|
US4478818A
(en)
*
|
1982-12-27 |
1984-10-23 |
Alza Corporation |
Ocular preparation housing steroid in two different therapeutic forms
|
|
US5229128A
(en)
*
|
1986-06-11 |
1993-07-20 |
Haddad Heskel M |
Drug delivery ophthalmic insert and method of preparing same
|
|
JPH01308232A
(ja)
*
|
1988-06-03 |
1989-12-12 |
Takeda Chem Ind Ltd |
固型医薬およびその製造法
|
|
FR2690846B1
(fr)
*
|
1992-05-05 |
1995-07-07 |
Aiache Jean Marc |
Forme galenique pour administration oculaire et procede de preparation.
|
|
US5948822A
(en)
|
1996-12-17 |
1999-09-07 |
Lidak Pharmaceuticals |
Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
|
|
CA2414674A1
(en)
*
|
2000-07-13 |
2002-01-24 |
Pharmacia Corporation |
Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
|
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
|
US20030220376A1
(en)
*
|
2001-08-10 |
2003-11-27 |
Pharmacia Corporation |
Methods for treating carbonic anhydrase mediated disorders
|
|
EA200400535A1
(ru)
*
|
2001-10-16 |
2005-06-30 |
Аванир Фармасютикалз |
ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
|
|
US20050074443A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Treadwell Benjamin V. |
Methods of attenuating autoimmune disease and compositions useful therefor
|
|
US20090092574A1
(en)
|
2006-12-29 |
2009-04-09 |
Scott Richard W |
Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
|
|
WO2014124458A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases
|
|
EP2970145B1
(en)
|
2013-03-11 |
2020-05-06 |
The Broad Institute, Inc. |
Compounds and compositions for the treatment of cancer
|
|
CA2939219C
(en)
|
2014-02-11 |
2023-02-28 |
Mitokinin Llc |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
WO2016172712A2
(en)
|
2015-04-23 |
2016-10-27 |
Sydnexis, Inc. |
Ophthalmic composition
|
|
US9421199B2
(en)
|
2014-06-24 |
2016-08-23 |
Sydnexis, Inc. |
Ophthalmic composition
|
|
US11382909B2
(en)
|
2014-09-05 |
2022-07-12 |
Sydnexis, Inc. |
Ophthalmic composition
|
|
JP2018521000A
(ja)
|
2015-05-29 |
2018-08-02 |
シドネキシス，インク． |
Ｄ２ｏで安定化された医薬製剤
|
|
SI3344248T1
(sl)
|
2015-09-02 |
2022-07-29 |
Trevena, Inc. |
6-členske aza-heterociklične spojine za modulacijo, ki vsebujejo delta-opioidne receptorje, metode uporabe in izdelave
|
|
CA3052479A1
(en)
|
2017-02-17 |
2018-08-23 |
Trevena, Inc. |
7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
|
|
BR112019016827A2
(pt)
|
2017-02-17 |
2020-04-07 |
Trevena Inc |
compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
|
|
CA3067695A1
(en)
|
2017-06-21 |
2018-12-27 |
Mitokinin, Inc. |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
US11471426B2
(en)
|
2019-10-16 |
2022-10-18 |
American River Nutrition, Llc |
Compositions comprising quinone and/or quinol and methods of preparations and use thereof
|